The Accumulation Distribution reference data for Silence Therapeutics is derived from the equity's published trading history. Forecast values and accuracy indicators are summarized on this page for reference.
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume All forecast values on this page for Silence Therapeutics PLC are Accumulation Distribution reference data derived from historical price series.
Accumulation Distribution Analysis Today
Silence Therapeutics PLC has current Accumulation Distribution of 12352.58. The accumulation distribution (A/D) indicator shows the degree to which Silence Therapeutics is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Silence Therapeutics PLC to determine if accumulation or reduction is taking place in the market. This value is adjusted by Silence Therapeutics trading volume to give more weight to distributions with higher volume over lower volume.
On March 20 2026 Silence Therapeutics PLC was traded for 6.17 at the closing time. Highest Silence Therapeutics's price during the trading hours was 6.40 and the lowest price during the day was 6.09 . The net volume was 255 K. The overall trading history on the 20th of March did not result in any price rise and fall. The trading price change to current price is 3.57% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Other Forecasting Options for Silence Therapeutics
For both new and experienced investors in Silence, the ability to analyze Silence Therapeutics' price movement is a fundamental investment skill. Price chart noise in Silence Stock can create false signals and mislead investment decisions.
The following equities are related to Silence Therapeutics within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Silence Therapeutics against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
Tracking market strength indicators for Silence Therapeutics provides context for understanding the momentum dynamics of the stock in real time. These signals support informed decisions about when to enter or exit positions in Silence Therapeutics PLC for maximum return potential.
Properly assessing Silence Therapeutics' risk indicators is a prerequisite for building reliable price forecasts. Identifying and quantifying the risks associated with Silence Therapeutics' allows investors to make better-informed decisions about accepting or hedging their exposure.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Silence Therapeutics
Story coverage around Silence Therapeutics PLC often expands when market conditions, narrative momentum, or risk-adjusted performance make the security more visible to investors. A disciplined read of coverage separates durable relevance from temporary noise.
Short-interest signals around Silence Therapeutics PLC can help investors judge whether skeptical positioning is starting to pressure price predictability and market tone. The practical goal is to identify when the balance between long and short participation may be changing the quality of the setup.
Common Stock Shares Outstanding
47.2 M
Cash And Short Term Investments
85.1 M
More Resources for Silence Stock Analysis
A clear view of Silence Therapeutics PLC comes from reviewing its financial structure and trends. These measures summarize how the business operates financially.
